News Room

A new international consensus guidance publication will help advance efforts to detect type 1 diabetes (T1D) earlier, before symptoms appear and before insulin therapy is needed.

Canada’s largest type 1 diabetes organization, formerly JDRF, urges federal partnership to establish a national network that would accelerate T1D cures and position Canada as a global hub for cell therapy clinical trials.

This letter was authored by Breakthrough T1D Canada President and Chief Executive Officer Jessica Diniz.

UPDATE: January 5, 2026 – Canada’s Drug Agency has just announced a decision not to reimburse Tzield (teplizumab) In Canada, reimbursement of therapeutics is based on recommendations from Canada’s Drug Agency (CDA) and Quebec’s Institut national d’excellence en santé et en services sociaux (INESSS).

The following Op Ed was co-authored by Breakthrough T1D’s President and CEO, Jessica Diniz and Cate Murray, President and CEO of the Stem Cell Network and was published in the Hill Times on October 30.

CFKF will be proudly naming the Breakthrough T1D Canucks For Kids Fund Centre of Excellence at UBC.

To our valued supporters and stakeholders: As you may know, as of September 25, 2025, Canada Post workers have gone on strike, resulting in nationwide service disruptions.

October 1, 2025 – One of Canada’s longest running and top fundraising events and the country’s premier team stationary cycling event will be taking place in Montréal, Québec and Toronto, Ontario on October 9 and 16 respectively.

EL SEGUNDO, Calif. — (BUSINESS WIRE) — Mattel, Inc. (NASDAQ: MAT) announced today that Barbie® is debuting the first Barbie doll with type 1 diabetes (T1D).

Throughout June close to 50 communities will be gathering across Canada to raise funds for type 1 diabetes research.

May 22, 2025 – Newfoundland and Labrador – Starting this fall, anyone living with T1D in Newfoundland and Labrador who meets the medical and income-testing criteria will be eligible for full or partial coverage of continuous glucose monitors.

Breakthrough T1D Board Member Matt Varey is cycling across Canada in support of type 1 diabetes research.